Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

To mark Rare Disease Day, Dr Noemi Roy talks about a two year project working with patients with rare forms of anaemia, and how she hopes this will translate into research in this area in a new Oxford Science Blog.

Rare Disease Day. It’s only one day, right? Like yesterday was International Polar Bear day, and tomorrow will be Employee Appreciation Day. Now, I have nothing against polar bears, and I’m all for appreciating employees. But let’s spend more than a day thinking about rare diseases. Rare diseases sound, well, rare, and “nothing to do with me, really.”

In fact, there are “over 6,000 rare diseases that affect over 300 million people worldwide”. This works out to 1 in 17 people being affected by a rare disease at some point in their life.

I am a researcher at the MRC Weatherall Institute of Molecular Medicine at the University of Oxford, but also a clinician looking after patients with rare inherited anaemias. These patients are born with a genetic abnormality that means they either can’t make red blood cells at all, can’t make enough normal ones, or their red blood cells are fragile and get destroyed too early. Not enough red blood cells means not enough oxygen to the body. Some patients suffer with fatigue and weakness and can’t keep up with their peers in normal daily activities, while others need blood transfusions. At the worst end of the spectrum are patients whose lives depend on blood transfusions every three weeks from birth.

Read more (University of Oxford website)

Similar stories

Cancer Research UK to invest £11 million into cancer science in Oxford

A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.

Review highlights risk factors associated with violence in schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.